Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Oleanolic acid 28-O-β-D-glucopyranoside | 14162-53-9 | 5 MG
SDP

Catalog No. 5000419025
Encompass_Preferred

Oleanolic acid 28-O-β-D-glucopyranoside is an orally active pentacyclic triterpenoid compound with anti-inflammatory effects. It inhibits inflammatory responses, enhances intestinal epithelial barrier function, and modulates gut microbiota in ulcerative colitis models. Its mechanism of action is related to the PI3K-AKT and MAPK signaling pathways and can be used in research for diseases such as colitis.

  • Orally active pentacyclic triterpenoid compound with anti-inflammatory effects
  • Inhibits inflammatory responses and modulates gut microbiota
  • Enhances intestinal epithelial barrier function
  • Targets IL-6 and COX-2 pathways
  • Increases transepithelial electrical resistance (TEER) and tight junction protein expression in Caco-2 cells
  • Reduces inflammatory cytokines (IL-6, TNF-α, COX-2, iNOS) in Caco-2 cells
  • Ameliorates ulcerative colitis in mouse models by reducing inflammation and improving colon health

Catalog No. 50-004-19025 Supplier Medchemexpress LLC Supplier No. HYN76355MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Oleanolic acid 28-O-β-D-glucopyranoside is an orally active pentacyclic triterpenoid compound with anti-inflammatory effects. It inhibits inflammatory responses, enhances intestinal epithelial barrier function, and modulates gut microbiota in ulcerative colitis models. Its mechanism of action is related to the PI3K-AKT and MAPK signaling pathways and can be used in research for diseases such as colitis.

  • Orally active pentacyclic triterpenoid compound with anti-inflammatory effects
  • Inhibits inflammatory responses and modulates gut microbiota
  • Enhances intestinal epithelial barrier function
  • Targets IL-6 and COX-2 pathways
  • Increases transepithelial electrical resistance (TEER) and tight junction protein expression in Caco-2 cells
  • Reduces inflammatory cytokines (IL-6, TNF-α, COX-2, iNOS) in Caco-2 cells
  • Ameliorates ulcerative colitis in mouse models by reducing inflammation and improving colon health

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.